| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 01/17/2002 | WO2002004434A1 Colchinol derivatives as vascular damaging agents |
| 01/17/2002 | WO2002004429A1 Pyrimidine derivatives |
| 01/17/2002 | WO2002004402A1 Ester derivatives |
| 01/17/2002 | WO2002004015A1 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use |
| 01/17/2002 | WO2002004002A2 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals |
| 01/17/2002 | WO2002003990A2 Use of substituted insole compounds for treating excessive intraocular pressure |
| 01/17/2002 | WO2001062726A3 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 01/17/2002 | WO2001047922A3 Azaindoles |
| 01/17/2002 | WO2001038878A3 Pin1 as a marker for abnormal cell growth |
| 01/17/2002 | WO2001038303A3 Vitamin d analogues |
| 01/17/2002 | WO2001035948A3 Neurophilin ligands for treating ocular conditions |
| 01/17/2002 | WO2001034553A3 2,2-difluoro 15-hydroxyeicosatetraenoic acid analogs and methods of use |
| 01/17/2002 | WO2001034552A3 Benzenoid derivatives of 15-hydroxyeicosatetraenoic acid and methods of their use in treating dry eye disorders |
| 01/17/2002 | WO2001030362A3 Ribozyme therapy for the treatment of proliferative skin and eye diseases |
| 01/17/2002 | WO2001022972A3 Immunostimulatory nucleic acids |
| 01/17/2002 | WO2001021259A3 Use and compositions for treating platelet-related disorders using anagrelide |
| 01/17/2002 | WO2001021161A3 Use of desloratadine for treating allergic and inflammatory conditions |
| 01/17/2002 | WO2001016293A3 Dna encoding the human serine protease t |
| 01/17/2002 | WO2001012598A3 METHODS OF INHIBITING BINDING OF β-SHEET FIBRIL TO RAGE AND CONSEQUENCES THEREOF |
| 01/17/2002 | WO2001007471A3 Cell cycle and proliferation proteins |
| 01/17/2002 | WO2000078953A3 Human transport proteins |
| 01/17/2002 | WO2000078952A3 Human rna metabolism proteins (rmep) |
| 01/17/2002 | WO2000074649A3 Ophthalmic histamine compositions and uses thereof |
| 01/17/2002 | US20020007074 Imidazole derivatives having affinity for alpha2 receptors |
| 01/17/2002 | US20020007066 For treatment/prevention of infection of herpes simplex virus, varicella zoster virus, human cytomegalovirus, or epstein-Barr virus; enzyme inhibitors |
| 01/17/2002 | US20020007060 Enzyme inhibitors; connective tissue cells; antiarthritic agents; anticarcinogenic agents |
| 01/17/2002 | US20020006957 Method for the synthesis of compounds of formula I and their uses thereof |
| 01/17/2002 | US20020006951 Solid-state form of celecoxib having enhanced bioavailability |
| 01/17/2002 | US20020006947 Aryl substituted pyrazoles, triazoles, and tetrazoles, and the use thereof |
| 01/17/2002 | US20020006946 Obesity, antidiabetic agents, cardiovascular disorders |
| 01/17/2002 | US20020006932 Central nervous system disorders; heeadaches, antiinflammatory agents |
| 01/17/2002 | US20020006888 Novel quaternary ammonium salt and process for the preparation thereof |
| 01/17/2002 | US20020006410 Method for treating inflammatory diseases using heat shock proteins |
| 01/17/2002 | DE10005302A1 Substituierte 1,2,3,4-Tetrahydrochinolin-2-carbonsäurederivate Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives |
| 01/17/2002 | CA2415468A1 Ester derivatives |
| 01/17/2002 | CA2414387A1 Drug metabolizing enzymes |
| 01/17/2002 | CA2412764A1 Stimulation of cellular regeneration and differentiation in the inner ear |
| 01/17/2002 | CA2412162A1 Chemokine receptor modulators, production and use |
| 01/17/2002 | CA2412150A1 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use |
| 01/17/2002 | CA2411160A1 Colchinol derivatives as vascular damaging agents |
| 01/16/2002 | EP1172113A1 Remedies for autonomic neuropathy |
| 01/16/2002 | EP1172098A1 Pharmaceutical compositions comprising ketotifen |
| 01/16/2002 | EP1171626A1 50 human secreted proteins |
| 01/16/2002 | EP1171591A1 48 human secreted proteins |
| 01/16/2002 | EP1171590A1 50 human secreted proteins |
| 01/16/2002 | EP1171579A1 Human tumor necrosis factor receptor tr9 |
| 01/16/2002 | EP1171573A1 Arpe-19 as a platform cell line for encapsulated cell-based delivery |
| 01/16/2002 | EP1171458A1 50 human secreted proteins |
| 01/16/2002 | EP1171457A1 46 human secreted proteins |
| 01/16/2002 | EP1171425A1 Use of maduraphthalazine derivatives as inhibitors of pro-inflammatory cytokins |
| 01/16/2002 | EP1171423A1 Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands |
| 01/16/2002 | EP1171422A1 Mmp inhibitor |
| 01/16/2002 | EP1171149A1 Inhibition of proteasome function induces programmed cell death in endothelial cells |
| 01/16/2002 | EP1171147A1 Modulation of excitable tissue function by peripherally administered erythropoietin |
| 01/16/2002 | EP1171138A2 Use of 6-methylmercaptopurine riboside in ophthalmologic compositions |
| 01/16/2002 | EP1171130A1 Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same |
| 01/16/2002 | EP1171122A1 Pyrrolidine modulators of chemokine receptor activity |
| 01/16/2002 | EP1171107A1 Pharmaceutical composition effective against pathological conditions caused by bacteria, viruses, fungi, yeasts and protozoa |
| 01/16/2002 | EP1093374B1 Hypo-osmotic saline solutions, method for preparing same and medicines based on said solutions |
| 01/16/2002 | CN1331694A Antihistaminic spiro compounds |
| 01/16/2002 | CN1331692A Benzisozazoles and phenones as alpha antagonist |
| 01/16/2002 | CN1331691A Piperidines as CCR5 modulators |
| 01/16/2002 | CN1331688A Aminopyrazole derivatives |
| 01/16/2002 | CN1331680A N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors |
| 01/16/2002 | CN1331674A Sulfonamide hydroxamates |
| 01/16/2002 | CN1331604A Compsn. consisting of influenza virus surface proteins and dispensing device |
| 01/16/2002 | CN1077799C prevention of retinal injury and degeneration by specfic factors |
| 01/16/2002 | CN1077790C Agent for treating gluaucoma and agent for reducing eye pressure |
| 01/15/2002 | US6339101 Administering n-linked sulfonamide of an n-heterocyclic carboxylic acid derivative for therapy of nerve-related vision disorder, improving vision, therapy memory impairment or enhancing memory performance in an animal |
| 01/15/2002 | US6339094 2-acylaminopropanamines as tachykinin receptor antagonists |
| 01/15/2002 | US6339069 Administering formulation comprising pharmaceutically acceptable carrier; and, liposome comprising a bioactive agent and a lipid component, the lipid component comprising a peptide-lipid conjugate |
| 01/15/2002 | US6338848 Treating multiple sclerosis with immunoglobulins and interleukins |
| 01/10/2002 | WO2002002790A1 Peptide-mediated ocular cell transfection |
| 01/10/2002 | WO2002002775A2 Calpain protease 12 |
| 01/10/2002 | WO2002002757A2 Adenylyl and guanylyl cyclases |
| 01/10/2002 | WO2002002638A2 Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 01/10/2002 | WO2002002634A2 Human extracellular matrix and cell adhesion polypeptides |
| 01/10/2002 | WO2002002633A2 Transporters and ion channels |
| 01/10/2002 | WO2002002603A2 Protein modification and maintenance molecules |
| 01/10/2002 | WO2002002593A2 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof |
| 01/10/2002 | WO2002002587A1 B7-like polynucleotides, polypeptides, and antibodies |
| 01/10/2002 | WO2002002564A1 Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 01/10/2002 | WO2002002554A1 Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders |
| 01/10/2002 | WO2002002531A1 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 01/10/2002 | WO2002002526A1 Pharmaceutical compositions for controlling intraocular pressure |
| 01/10/2002 | WO2002002140A1 Vaccine comprising active agent immunogenic acyl glyceryl phosphatidylinositol manno-oligosaccharide |
| 01/10/2002 | WO2002002122A1 Ophthalmological drops with anti-imflammatory effect based on a wide-spectrum antibiotic and a local glucocorticoid |
| 01/10/2002 | WO2002002118A1 Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies |
| 01/10/2002 | WO2002002105A1 Therapeutic combinations of fatty acids |
| 01/10/2002 | WO2002002076A2 Methods for treating inflammation-mediated conditions of the eye |
| 01/10/2002 | WO2001059071A3 Methods of preparing and using a viral vector library |
| 01/10/2002 | WO2001042192A3 Vla-4 integrin antagonists |
| 01/10/2002 | WO2000055332A3 Human regulators of intracellular phosphorylation |
| 01/10/2002 | US20020004580 Polypeptide; for use in the diagnosis and treatment of microorganismal infections; bactericides |
| 01/10/2002 | US20020004527 Infant formulas containing long-chain polyunsaturated fatty acids and uses thereof |
| 01/10/2002 | US20020004516 Use of riluzole in the treating acoustic traumas |
| 01/10/2002 | US20020004039 Stimulating proliferation of neural progenitor cells with epidermal growth factor binding polypeptide; directing migration of progeny to neurological injury sight; stimulating cell differentiation at injury |
| 01/10/2002 | DE10031932A1 Calpain-Protease 12 Calpain protease 12 |
| 01/10/2002 | DE10019714A1 Salze von bicyclischen, N-acylierten Imidazo-3-aminen und Imidazo-5-aminen Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines |
| 01/10/2002 | CA2630062A1 Methods for treating graft versus host disease and immune disorders associated with rejection using a soluble ctla4 molecule |